| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
47,988 |
42,229 |
$2.81M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,862 |
16,485 |
$1.61M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40,061 |
32,938 |
$1.52M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
23,169 |
5,663 |
$1.38M |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,536 |
7,758 |
$1.11M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,919 |
4,936 |
$1.03M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
9,808 |
8,989 |
$685K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
20,926 |
16,327 |
$669K |
| 80053 |
Comprehensive metabolic panel |
45,667 |
33,487 |
$588K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,183 |
12,571 |
$575K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,599 |
7,616 |
$562K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,648 |
4,698 |
$476K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,852 |
4,496 |
$381K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,749 |
11,473 |
$358K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,043 |
5,006 |
$352K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,226 |
4,118 |
$330K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,006 |
6,091 |
$293K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,228 |
7,409 |
$265K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
16,993 |
4,644 |
$218K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
6,222 |
5,096 |
$217K |
| 97161 |
|
1,637 |
1,525 |
$200K |
| 82947 |
|
15,834 |
7,655 |
$198K |
| 81025 |
|
8,378 |
7,146 |
$194K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14,725 |
10,460 |
$191K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,508 |
2,075 |
$177K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
2,712 |
2,394 |
$176K |
| 71046 |
Radiologic examination, chest; 2 views |
8,760 |
7,407 |
$171K |
| 0225U |
|
1,345 |
1,291 |
$168K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,257 |
2,194 |
$123K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,122 |
1,987 |
$123K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
7,234 |
2,444 |
$118K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,150 |
4,982 |
$117K |
| 81003 |
|
10,556 |
8,955 |
$115K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,109 |
968 |
$114K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,646 |
1,393 |
$112K |
| 71045 |
Radiologic examination, chest; single view |
18,731 |
14,991 |
$112K |
| 81001 |
|
21,086 |
17,580 |
$105K |
| 97162 |
|
1,379 |
1,187 |
$94K |
| G0378 |
Hospital observation service, per hour |
17,225 |
8,464 |
$93K |
| 73610 |
|
1,661 |
1,422 |
$89K |
| 86901 |
|
4,147 |
3,439 |
$84K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,404 |
1,422 |
$83K |
| 73564 |
|
2,113 |
1,660 |
$79K |
| 97163 |
|
1,082 |
891 |
$62K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,155 |
1,808 |
$62K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,204 |
1,301 |
$58K |
| 86850 |
|
2,154 |
1,745 |
$57K |
| 73630 |
|
1,928 |
1,614 |
$57K |
| 73130 |
|
1,525 |
1,308 |
$55K |
| 73110 |
|
1,006 |
877 |
$54K |
| 73030 |
|
1,518 |
1,226 |
$53K |
| 01999 |
|
3,890 |
3,265 |
$52K |
| 76830 |
Ultrasound, transvaginal |
1,392 |
1,187 |
$52K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
57,618 |
40,242 |
$51K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
597 |
499 |
$50K |
| 87210 |
|
4,636 |
3,965 |
$49K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,165 |
7,783 |
$48K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,192 |
1,864 |
$48K |
| 12011 |
|
583 |
545 |
$48K |
| 87807 |
|
560 |
522 |
$46K |
| 97116 |
|
1,616 |
701 |
$45K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
447 |
361 |
$45K |
| 87070 |
|
4,743 |
4,295 |
$44K |
| 12001 |
|
577 |
541 |
$44K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,219 |
1,911 |
$42K |
| 96376 |
|
6,756 |
3,692 |
$40K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,466 |
2,248 |
$37K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
349 |
318 |
$36K |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
490 |
455 |
$35K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
530 |
504 |
$34K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,154 |
1,036 |
$34K |
| 93971 |
|
1,332 |
1,121 |
$33K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
486 |
437 |
$32K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,385 |
1,851 |
$31K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
31,362 |
22,101 |
$30K |
| 10060 |
|
509 |
444 |
$30K |
| 74018 |
|
1,158 |
958 |
$29K |
| 84484 |
|
25,600 |
14,942 |
$28K |
| 87186 |
|
3,298 |
2,657 |
$26K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,480 |
2,051 |
$26K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
450 |
222 |
$25K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
720 |
561 |
$24K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,856 |
20,772 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
974 |
894 |
$24K |
| 74019 |
|
1,039 |
962 |
$24K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
552 |
501 |
$23K |
| A4649 |
Surgical supply; miscellaneous |
68 |
56 |
$22K |
| 92587 |
|
521 |
479 |
$22K |
| 97535 |
Self-care/home management training, each 15 minutes |
950 |
518 |
$22K |
| 36415 |
Collection of venous blood by venipuncture |
2,788 |
1,951 |
$21K |
| 73080 |
|
576 |
506 |
$21K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
57 |
51 |
$19K |
| 82077 |
|
945 |
806 |
$18K |
| 73502 |
|
857 |
642 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,598 |
10,643 |
$17K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,155 |
1,055 |
$16K |
| 76801 |
|
3,014 |
2,459 |
$16K |
| 87430 |
|
918 |
870 |
$15K |
| 73140 |
|
212 |
190 |
$15K |
| 73090 |
|
387 |
347 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,013 |
722 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,994 |
4,307 |
$14K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,594 |
3,653 |
$13K |
| 93970 |
|
614 |
485 |
$13K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,650 |
2,811 |
$13K |
| 93017 |
|
707 |
586 |
$12K |
| 80050 |
General health panel |
486 |
459 |
$11K |
| 88304 |
|
549 |
415 |
$11K |
| 82803 |
|
950 |
739 |
$11K |
| 87634 |
|
1,168 |
1,105 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,071 |
2,961 |
$11K |
| 74022 |
|
755 |
636 |
$11K |
| 72131 |
|
619 |
496 |
$10K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,353 |
1,427 |
$10K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,128 |
1,018 |
$10K |
| 59025 |
Fetal non-stress test |
188 |
152 |
$10K |
| 12002 |
|
166 |
152 |
$10K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
247 |
179 |
$9K |
| 84703 |
|
15,420 |
12,683 |
$9K |
| 85610 |
|
7,106 |
5,372 |
$9K |
| 72110 |
|
555 |
430 |
$9K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
260 |
215 |
$9K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,852 |
1,298 |
$8K |
| 85730 |
|
5,515 |
4,316 |
$8K |
| 84702 |
|
5,263 |
4,186 |
$7K |
| 70486 |
|
392 |
311 |
$7K |
| 73590 |
|
303 |
248 |
$7K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
391 |
163 |
$7K |
| 83880 |
|
5,582 |
4,461 |
$7K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
6,864 |
4,811 |
$7K |
| 83690 |
|
13,502 |
10,823 |
$6K |
| 87040 |
|
7,302 |
3,702 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,877 |
4,193 |
$5K |
| 83735 |
|
8,837 |
6,729 |
$5K |
| 93976 |
|
362 |
303 |
$5K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
157 |
121 |
$5K |
| 86900 |
|
4,158 |
3,450 |
$5K |
| 80061 |
Lipid panel |
2,535 |
2,050 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,726 |
7,591 |
$5K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,426 |
1,145 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,060 |
1,420 |
$4K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
976 |
745 |
$4K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
113 |
88 |
$4K |
| 83605 |
|
5,950 |
4,311 |
$4K |
| 77334 |
|
16 |
12 |
$4K |
| 85045 |
|
473 |
233 |
$4K |
| 70491 |
|
46 |
44 |
$4K |
| 99152 |
|
873 |
679 |
$4K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
49 |
43 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,077 |
1,615 |
$3K |
| 71101 |
|
60 |
52 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
377 |
343 |
$3K |
| 85379 |
|
2,687 |
2,287 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
519 |
492 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,119 |
1,721 |
$3K |
| 82565 |
|
1,395 |
1,138 |
$3K |
| 94760 |
|
1,818 |
1,216 |
$3K |
| C1769 |
Guide wire |
983 |
649 |
$2K |
| 84295 |
|
264 |
212 |
$2K |
| 88342 |
|
1,296 |
1,111 |
$2K |
| 36430 |
|
132 |
102 |
$2K |
| 86140 |
|
2,151 |
1,892 |
$2K |
| 80076 |
|
133 |
118 |
$2K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
106 |
78 |
$2K |
| 82247 |
|
135 |
96 |
$2K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
15 |
15 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
277 |
226 |
$2K |
| 84132 |
|
1,037 |
794 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
110 |
85 |
$2K |
| 99153 |
Mod sedat endo service >5yrs |
388 |
291 |
$2K |
| 85027 |
|
3,119 |
2,264 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,169 |
3,483 |
$1K |
| 90715 |
|
1,345 |
1,098 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,188 |
3,818 |
$1K |
| 94770 |
|
88 |
54 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
1,960 |
1,513 |
$1K |
| 82731 |
|
12 |
12 |
$1K |
| 73060 |
|
28 |
24 |
$1K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
60 |
52 |
$1K |
| 70360 |
|
28 |
27 |
$1K |
| 87077 |
|
2,322 |
1,805 |
$1K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
286 |
218 |
$1K |
| 85014 |
|
433 |
315 |
$897.30 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
470 |
355 |
$896.22 |
| 84145 |
|
1,080 |
863 |
$888.16 |
| 96367 |
|
613 |
473 |
$868.81 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
3,205 |
2,530 |
$855.46 |
| 82330 |
|
254 |
189 |
$769.88 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
599 |
451 |
$731.53 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
547 |
452 |
$603.23 |
| 82550 |
|
1,590 |
1,242 |
$568.59 |
| J2785 |
Injection, regadenoson, 0.1 mg |
509 |
416 |
$562.49 |
| 84100 |
|
334 |
266 |
$551.56 |
| 86923 |
|
71 |
43 |
$538.53 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
40 |
38 |
$524.16 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
1,479 |
754 |
$485.49 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
102 |
39 |
$479.47 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
40 |
37 |
$477.00 |
| 76882 |
|
16 |
12 |
$429.96 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,116 |
862 |
$355.15 |
| 82570 |
|
80 |
65 |
$349.50 |
| 71250 |
|
38 |
25 |
$341.34 |
| 76870 |
|
29 |
27 |
$325.92 |
| 76775 |
|
26 |
25 |
$319.18 |
| 93880 |
|
33 |
25 |
$304.18 |
| J1630 |
Injection, haloperidol, up to 5 mg |
600 |
486 |
$304.00 |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
31 |
26 |
$298.04 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
542 |
419 |
$290.06 |
| 80164 |
|
132 |
89 |
$286.67 |
| 87641 |
|
189 |
145 |
$278.05 |
| 87045 |
|
13 |
12 |
$264.87 |
| C9113 |
Injection, pantoprazole sodium, per vial |
879 |
551 |
$258.20 |
| 95816 |
|
13 |
12 |
$230.83 |
| 93458 |
|
34 |
24 |
$213.94 |
| 87486 |
|
482 |
434 |
$181.90 |
| 87653 |
|
12 |
12 |
$163.90 |
| 94761 |
|
45 |
35 |
$162.35 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,061 |
607 |
$144.20 |
| 82435 |
|
186 |
155 |
$140.09 |
| 84520 |
|
127 |
105 |
$140.09 |
| 29125 |
|
131 |
116 |
$123.18 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,057 |
698 |
$120.63 |
| 87581 |
|
459 |
416 |
$107.56 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
650 |
287 |
$78.53 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
172 |
125 |
$75.67 |
| 97167 |
|
61 |
50 |
$61.15 |
| 82607 |
|
54 |
39 |
$22.85 |
| 82140 |
|
129 |
94 |
$19.92 |
| 85652 |
|
692 |
612 |
$11.70 |
| 80185 |
|
14 |
12 |
$7.35 |
| 85018 |
|
56 |
39 |
$6.39 |
| J2704 |
Injection, propofol, 10 mg |
61 |
42 |
$6.36 |
| 84439 |
|
88 |
65 |
$4.57 |
| 84550 |
|
39 |
37 |
$3.15 |
| 82248 |
|
112 |
85 |
$2.95 |
| 84156 |
|
30 |
24 |
$2.95 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
551 |
290 |
$0.00 |
| 90686 |
|
169 |
137 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
1,405 |
436 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
261 |
126 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
359 |
235 |
$0.00 |
| 87205 |
|
68 |
51 |
$0.00 |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
14 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
45 |
35 |
$0.00 |
| 87046 |
|
13 |
12 |
$0.00 |
| 72128 |
|
15 |
13 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
17 |
14 |
$0.00 |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
15 |
12 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
457 |
254 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
22 |
22 |
$0.00 |
| 80179 |
|
160 |
139 |
$0.00 |
| 36600 |
|
85 |
63 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
138 |
117 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
186 |
142 |
$0.00 |
| 72100 |
|
15 |
12 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
15 |
13 |
$0.00 |
| 80074 |
|
15 |
13 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
22 |
12 |
$0.00 |
| 83540 |
|
16 |
12 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
15 |
13 |
$0.00 |